Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

The price tag on progress--chemotherapy for colorectal cancer.

Schrag D.

N Engl J Med. 2004 Jul 22;351(4):317-9. No abstract available.

PMID:
15269308
2.

[Progress of chemotherapy in colorectal cancer].

Komatsu Y.

Gan To Kagaku Ryoho. 2007 Nov;34(11):1771-6. Review. Japanese. No abstract available.

PMID:
18064761
3.

New combinations in metastatic colorectal cancer: what are our expectations?

Hurwitz H.

Oncologist. 2005 May;10(5):320-2. Review. No abstract available.

4.

Cetuximab (erbitux).

Bou-Assaly W, Mukherji S.

AJNR Am J Neuroradiol. 2010 Apr;31(4):626-7. doi: 10.3174/ajnr.A2054. Epub 2010 Feb 18. Review.

5.

[Present status of chemotherapy for colorectal cancer in countries outside of Japan].

Doi T, Ohtsu A.

Nihon Rinsho. 2003 Sep;61 Suppl 7:368-73. Review. Japanese. No abstract available.

PMID:
14574915
6.

[Application of monoclonal antibody in combination with irinotecan in the treatment of colorectal cancer].

Li J.

Zhonghua Zhong Liu Za Zhi. 2006 Oct;28(10):796-7. Review. Chinese. No abstract available.

PMID:
17366800
7.

The cost-effectiveness of bevacizumab in the first-line treatment of metastatic colorectal cancer in England and Wales.

Tappenden P, Jones R, Paisley S, Carroll C.

Eur J Cancer. 2007 Nov;43(17):2487-94. Epub 2007 Oct 1. Review.

PMID:
17910914
8.

New developments in systemic chemotherapy in advanced colorectal cancer.

Cats A.

Scand J Gastroenterol Suppl. 2003;(239):78-86. Review.

PMID:
14743888
9.

Progress in the development of novel treatments for colorectal cancer.

Hoff PM, Pazdur R.

Oncology (Williston Park). 2004 May;18(6):705-8. Review.

PMID:
15214591
10.

Systemic therapy for colorectal cancer.

Meyerhardt JA, Mayer RJ.

N Engl J Med. 2005 Feb 3;352(5):476-87. Review. No abstract available.

PMID:
15689586
11.

[Biotherapy in colorectal cancer].

Des Guetz G.

J Chir (Paris). 2005 Sep-Oct;142(5):291-6. Review. French.

PMID:
16292207
12.

[Cetuximab].

Takiuchi H.

Gan To Kagaku Ryoho. 2007 Aug;34(8):1192-5. Review. Japanese.

PMID:
17687200
13.

Synergy between cetuximab and chemotherapy in tumors of the gastrointestinal tract.

Mahtani RL, Macdonald JS.

Oncologist. 2008 Jan;13(1):39-50. doi: 10.1634/theoncologist.2006-0049. Review.

14.
15.

[Palliative chemotherapy and radiotherapy for metastatic colorectal cancer].

Sørbye H, Braendengen M, Balteskard L.

Tidsskr Nor Laegeforen. 2008 Jan 17;128(2):194-7. Review. Norwegian.

16.

[New therapy options in colorectal carcinoma].

Folprecht G, Köhne CH.

Ther Umsch. 2004 Jun;61(6):373-8. Review. German.

PMID:
15253162
17.

Second-line treatment of patients with metastatic colorectal cancer.

Rougier P, Lepere C.

Semin Oncol. 2005 Dec;32(6 Suppl 9):S48-54. Review.

PMID:
16399432
18.

[Economic assessment of adjuvant and palliative chemotherapy in colorectal cancer: a review].

Selke B, Lebrun T, Comte S.

Bull Cancer. 2003 Feb;90(2):143-9. Review. French.

19.

Economics of ramucirumab for metastatic colorectal cancer.

Zeichner SB, Kohn CG, Goldstein DA.

Expert Rev Pharmacoecon Outcomes Res. 2016 Dec;16(6):733-745. Review.

PMID:
27828732

Supplemental Content

Support Center